Indianapolis — Indianapolis, Indiana

Indianapolis is a clinical research site located in Indianapolis, Indiana, United States 46202.

Crixeo Health Trust Score: 73/100 (FAIR). This profile has not yet been claimed by the site owner.

Indianapolis has participated in 7 clinical trials with 2 currently active.

Therapeutic areas: Clostridium Difficile Infection Recurrence, Clostridium Difficile Infection, Recurrent Clostridium Difficile Infection.

Sponsors: Finch Research and Development LLC., Tectonic Therapeutic, Promontory Therapeutics Inc..

Sponsor Feasibility Report

Trust Score: 73/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Indianapolis?

Indianapolis has a Crixeo Trust Score of 73/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Indianapolis conducted?

Indianapolis has 7 clinical trials on record, with 2 currently active. Their work covers Clostridium Difficile Infection Recurrence, Clostridium Difficile Infection, Recurrent Clostridium Difficile Infection.

Is Indianapolis accredited by Crixeo Health?

Yes — Indianapolis holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Indianapolis?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.